Results 171 to 180 of about 715,613 (310)

Brain-kidney crosstalk in subarachnoid hemorrhage patients. [PDF]

open access: yesJ Crit Care Med (Targu Mures)
Monteiro E   +7 more
europepmc   +1 more source

Hydrocephalus and Diffuse Alveolar Hemorrhage as the Initial Manifestation of Systemic Lupus Erythematosus and Antiphospholipid Syndrome: A Case Report

open access: yesClinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT Systemic lupus erythematosus (SLE) is an autoimmune disease that can affect many systems, such as the central nervous system (CNS), cardiovascular, musculocutaneous, renal, and respiratory systems, etc. SLE can occur alone or in association with other autoimmune diseases, especially antiphospholipid syndrome (APS).
Ehsan Adib   +3 more
wiley   +1 more source

Successful Application of Extra‐Intracranial Microanastomosis in the Management of Giant Intracranial Aneurysms: A Clinical Case

open access: yesClinical Case Reports, Volume 14, Issue 9, September 2026.
ABSTRACT We report a case of a giant middle cerebral artery aneurysm treated with a staged strategy: initial extracranial–intracranial revascularization via superficial temporal artery–M4 bypass, followed by definitive endovascular aneurysm exclusion with detachable microcoil embolization.
Ruzikulov M. Mazhidovich   +10 more
wiley   +1 more source

Beyond the Black Box: Is Artificial Intelligence Ready to Reshape Neurosurgical Decision‐Making? A Narrative Review

open access: yesHealth Science Reports, Volume 9, Issue 9, September 2026.
ABSTRACT Background and Aims Artificial intelligence (AI) is increasingly being integrated into neurosurgical practice, offering capabilities in diagnostic imaging, surgical planning, and outcome prediction. However, the “black box” nature of many AI systems generating recommendations without a transparent rationale poses fundamental challenges to ...
Dip Bahadur Singh   +2 more
wiley   +1 more source

Icariside II in Neurological Disorders: Mechanistic Insights Into Alzheimer's Disease, Cerebral Ischemia and Parkinson's Disease

open access: yesJournal of Biochemical and Molecular Toxicology, Volume 40, Issue 9, September 2026.
The graphical abstract represents the underlying neuroprotective potential of ICS II against Alzheimer's disease, Cerebral ischemia and Parkinson disease. ICS II downregulates ROS production, inflammation, mitochondrial dysfunction and apoptosis along with regulating their key signalling pathways.
Ashutosh Solanki   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy